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Abstract
Glutamate, a major excitatory neurotransmitter in the mammalian central nervous sys-
tem, plays a vital role in many physiological processes and is one of the key neurotrans-
mitters of interest in psychopharmacology. It is involved in many normal and abnormal 
behaviors related to neurological and psychiatric disorders. The glutamate system has 
been proposed to play a significant role in various neurological and psychiatric disor-
ders such as Alzheimer’s disease, autism, schizophrenia, depression, drug addiction, and 
more. The design, construction, and optimization of enzyme-based electrochemical bio-
sensors for in vivo and in vitro detection of glutamate are active areas of interdisciplinary 
research. For example, various glutamate biosensors have been developed for monitoring 
dynamic levels of extracellular glutamate in the living brain tissue adding to the current 
medical knowledge of these complex neurotransmitter systems and ultimately impact-
ing treatment plans. In addition to biological sciences and clinical medicine, glutamate 
biosensors have been used in environmental monitoring, in the fermentation industry, 
and in the food industry for determination of monosodium glutamate (MSG), a common 
flavor-enhancing food additive.
Keywords: biocatalytic sensors, L-glutamate, mediator, monosodium glutamate, carbon 
nanotubes, nanomaterials, neurological and psychiatric disorders, glutamate oxidase, 
glutamate dehydrogenase
1. Introduction
Glutamate is a nonessential amino acid, a precursor for gamma aminobutyric acid (GABA 
(the primary inhibitory neurotransmitter)), and an abundant excitatory neurotransmitter in 
the mammalian central nervous system that is produced by pyramidal cells located in the 
cerebral cortex and hippocampus. It has an important role in the formation and stabilization 
of synapses, long-term potentiation (i.e., the long-lasting enhancement in signal transmission 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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between two neurons which results from synchronously stimulating them), neurodegenera-
tive diseases, learning, and the formation of memories. In addition, maintaining a balance 
in glutamate levels in the central nervous system is important because increased levels lead 
to neurotoxicity and cell death, while decreased levels result in impaired long-term poten-
tiation, impaired synaptic plasticity (i.e., the ability of synapses to change their structures in 
response to inputs and changes in their environment), and impaired cognitive performance 
[1]. Glutamate also plays a pivotal role in cellular metabolism as it is associated with trans-
amination reaction, a key step in amino acid degradation, and is the product of deamination. 
Hence, quantifying glutamate levels in biological fluids and tissues reliably and reproducibly 
is of interest in many disciplines.
Glutamate dysregulation may induce excitotoxicity, which is closely associated with mul-
tiple psychiatric and cognitive disorders. Glutamate is hypothesized to have a key role in the 
pathophysiology of psychiatric disorders such as schizophrenia [2] and depression [3]. It is 
also currently a target of novel drugs for potential treatments of schizophrenia and depres-
sion. Briefly, the glutamate hypothesis of schizophrenia suggests that there is a hypofunction 
in N-methyl-D-Aspartate (NMDA)-type glutamate receptors within the glutamate system 
wherein the normal balance between excitatory glutamate and inhibitory GABA is destabi-
lized resulting in a combination of excitotoxicity and impaired neuroplasticity, which results 
in the psychotic symptoms of schizophrenia. As stated earlier, glutamate or glutamic acid is 
an excitatory amino acid neurotransmitter that is synthesized from the precursor amino acid 
glutamine, in cells called glia which protect and support neurons in the nervous system. In 
addition, glia recycle and regenerate glutamate after its release during neurotransmission. 
After glutamate is released from glutamate neurons, it binds to synaptic receptors and is then 
pumped into glia by an excitatory amino acid transporter (EAAT). Once in the glia, glutamate 
is converted into glutamine by the enzyme glutamate synthetase. Glutamine is released from 
glia via reverse transport either by the specific neutral amino acid transporter (SNAT) or by 
the alanine-serine-cysteine transporter (ASC-T) and transported into the neuron. Inside the 
neuron, glutamine is converted to glutamate by a mitochondrial enzyme called glutaminase 
for use as a neurotransmitter. After use, glutamate is stored in synaptic vesicles for subse-
quent release during neurotransmission, and its actions are terminated via removal by EAATs 
[4]. The next section will outline the proposed role of glutamate in schizophrenia.
2. Glutamate and schizophrenia
In the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), schizo-
phrenia is defined by a group of characteristic symptoms which consist of (1) psychotic or 
positive symptoms (i.e., symptoms characterized by the presence of something that should 
be absent, such as hallucinations or delusions), (2) disorganized symptoms (such as disor-
ganized speech–e.g., incoherence or frequent derailment, disorganized or catatonic behav-
ior, and inappropriate affect), (3) negative symptoms (i.e., symptoms characterized by the 
absence of something that should be present, such as avolition [lack of motivation], affective 
flattening [diminished emotional expression], or alogia [poverty of speech]), (4) deterioration 
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in social, occupational, or interpersonal relationships, and (5) continuous signs of the distur-
bance for at least 6 months [1].
Glutamate-based theories of schizophrenia resulted from the observation that two related 
compounds—phencyclidine (PCP) and ketamine—produced symptoms and cognitive def-
icits in healthy subjects which resembled those found in schizophrenia. These symptoms, 
including negative as well as positive symptoms, resolved following elimination of the com-
pounds. Years later, further research revealed that these compounds produced their effects 
by blocking neurotransmission at NMDA-type glutamate receptors which in turn gave rise to 
current glutamate-based models of schizophrenia. In addition, it has been found that many 
suspected genes for schizophrenia affect glutamate neurotransmission. Also, NMDA recep-
tors are regulated by brain levels of glycine, D-serine, and glutathione such that disturbances 
in concentrations of these compounds and of the genes related to their synthesis may all 
contribute to schizophrenia. Since available data to date suggests that there is more than one 
single cause of NMDA receptor dysfunction among different individuals, perhaps threshold 
models are more useful in that for each individual, the sum of genetic and environmental fac-
tors determines whether NMDA receptor functions will fall below a critical level. In schizo-
phrenia, it is postulated that psychosis may emerge once the level of NMDA receptor function 
decreases by approximately 20%, with worsening symptom severity thereafter. Furthermore, 
since glutamate and NMDA receptors are widely distributed throughout the brain, this has 
led to a concept of “whole brain” dysfunction, which involves the prefrontal, limbic, auditory, 
and visual cortices among others. Some specific examples of the consequences of glutamate 
deficits in certain brain regions include (1) working memory impairments and inability to 
unlearn dysfunctional behavior patterns due to glutamate deficits in the dorsolateral prefron-
tal cortex, (2) impaired response inhibition and hence an increased tendency for impulsiv-
ity and impulsive aggression due to glutamate deficits in the inferior prefrontal cortex, (3) 
impairments in learning and memory formation which contribute to psychosis and delusion 
formation due to glutamate deficits in the medial temporal cortex, (4) perceptual changes 
including impaired reading ability due to glutamate deficits in the visual cortex, and (5) 
impaired ability to detect vocal intonation which leads to impairments in emotional recog-
nition and social cognition due to glutamate deficits in the primary auditory cortex. Thus, 
widespread cognitive dysfunction in these brain regions due to dysfunctional glutamate and 
NMDA-type glutamate receptors represents a formidable obstacle that prevents individuals 
with schizophrenia from returning to premorbid levels of functioning [5].
3. Other applications of glutamate biosensors
In addition to its key roles in fundamental neurological processes and neurological disor-
ders, glutamate is important in protein synthesis, protein degradation, and nitrogen metabo-
lism. The concentrations of glutamate in intracellular environment vary from 2 to 20 mM [6]. 
Usual glutamate concentrations in plasma are approximately 150 and 10 μM in cerebrospi-
nal fluid [7, 8]. Normal glutamate concentration in the extracellular space ranges between 
1 and 80 μM [9]. The quantification of L-glutamate is also important in food analysis due to 
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questions about its safety as a food additive. Monosodium glutamate (MSG, C5H8NO4Na), invented by Dr. Kikunae Ikeda in 1908, is a commonly used flavor-enhancing additive found 
in Chinese restaurant food [10, 11], canned soups, canned vegetables, and processed meats. 
Interestingly, there has been controversy surrounding the use and safety of MSG as a food 
additive. According to some studies, excessive intake of MSG may cause headaches and stom-
ach pain in certain individuals as well as neuronal excitotoxicity. However, use of MSG as a 
food additive is generally regarded as harmless. Still, many food manufacturers choose to 
advertise their products as being MSG-free. Development of MSG biosensors for food applica-
tions is also an active area of research. For example, Monošík et al. recently prepared and char-
acterized a bienzymatic nanocomposite electrode for quantification of MSG in food samples, 
utilizing L-glutamate dehydrogenase and diaphorase enzymes immobilized between chitosan 
layers on nanocomposite electrodes consisting of multiwalled carbon nanotubes (MWCNTs) 
[12]. The structure of monosodium glutamate is shown in Figure 1.
4. Glutamate biosensors
This chapter will primarily focus on providing an overview about various enzyme-based glu-
tamate biosensors that utilize sensitive electrochemical detection methods. In addition, the 
characterization and optimization of newly developed enzyme-based electrochemical biosen-
sors will be discussed briefly. A brief overview of the most common electrochemical detection 
methods utilized in biocatalytic glutamate sensor characterization, testing, and in quantita-
tive analysis will also be provided. We will begin with a brief introduction to electrochemical 
biocatalytic sensors.
In general terms, biosensors are devices that register a biochemical reaction which is then 
converted into a signal that can be detected and quantified [13]. A typical biosensor con-
tains biological recognition molecules, such as enzymes, that are highly selective and specific 
for a given analyte. In electrochemical biocatalytic sensors, the biological recognition mol-
ecules bind reversibly to a particular analyte on or near an electrochemically active interface 
which may incorporate nanomaterials, giving rise to a measurable signal [13]. An electric 
transducer, usually a modified electrode, which is in contact with the electrochemically active 
Figure 1. The chemical structure of monosodium glutamate.
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interface, converts the biochemical reaction into an electrical signal that is further amplified 
by a signal processor into a useful form. The development of electrochemical biosensors for 
determination of glutamate is an active area of research as these sensors are typically easy to 
use, fast, reliable, convenient, portable, and affordable. Various instrumental analysis tech-
niques such as spectrophotometry [14, 15], chemiluminescence [16], capillary electrophore-
sis [17–19], gas chromatography [20], and high-performance liquid chromatography [21–23] 
have also been utilized in detecting glutamate. However, these methods can be expensive, 
time-consuming, labor intensive, often require sample preparation, and utilize sophisticated 
instruments which require trained personnel to operate. Specifically, chromatography meth-
ods often require analyte derivatization, while spectrophotometry requires tedious sample 
pretreatment procedures.
Glutamate biosensors have been developed for both in vitro and in vivo applications. One 
of the challenges surrounding the utilization of sensitive and selective in vivo monitor-
ing of dynamic levels of extracellular glutamate in living tissues using biosensors is that 
unlike an electroactive analyte such as dopamine, glutamate is nonelectroactive. Therefore, 
the direct measurement of glutamate using voltammetric electroanalytical techniques is 
not possible. However, if a biological recognition component such as an enzyme is added 
onto a physical transducer, in this case the electrode, the glutamate levels may be mea-
sured indirectly by quantifying one of the enzymatically generated products at the biocata-
lytic sensor [13]. A few commercial biosensors for routine glutamate measurements in the 
food industry are available from companies such as Yellow Springs Instruments (Yellow 
Springs, OH, USA).
Microdialysis methods have been widely used in monitoring extracellular glutamate levels in 
the brains of conscious animals. Yao and Okano described an in vivo flow-injection biosensor 
system with online microdialysis samples attempting to simultaneously determine the con-
centrations of L-glutamate, dopamine, and acetylcholine [24]. The triple electrode measured 
an average of 6 μM of L-glutamate in rat brain, whereas dopamine and acetylcholine levels 
were below the detection limit of the biosensor.
Furthermore, studies have shown that the glutamate detected using microdialysis is not or 
is only partly derived from synaptic transmission. As a result, development of appropriate 
biosensors for the accurate detection and monitoring of glutamate in vivo remains an ongoing 
endeavor. The ideal in vivo biosensors would be enzyme-based electrochemical biosensors in 
which a highly specific enzyme is immobilized on the surface of a sensitive electrochemical 
transducer. Indeed, certain authors have reported the fabrication and utilization of glutamate 
biosensors capable of second-by-second in vivo monitoring of glutamate levels in freely mov-
ing rats and mice [25, 26].
Nanotechnology and advances in microfabrication technology have played a crucial role in the 
fabrication of many biosensors. Nanoscale materials, with at least one dimension ranging in size 
from 10−7 to 10−9 m, have been incorporated into various enzymatic biosensors including many 
of the more recent L-glutamate sensors. The trend to manufacture smaller and more portable 
biosensor devices with improved performance has in part led to the incorporation of nano-
materials into biosensors. The unique chemical and physical properties of the nanomaterials 
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also enhance the analytical performance of these biosensors. The nanomaterials utilized include 
carbon nanotubes (CNTs), graphene, nanowires, carbon fibers, and metal nanoparticles (NPs). 
Electrochemical biosensors that incorporate nanomaterials such as CNTs on the transducer 
surface generally have very good conductivities and much greater surface areas onto which 
enzymes and other molecules may be immobilized.
Recently, combining the high bioselectivity and specificity of oxidoreductase enzymes with 
the numerous and advantageous chemical and physical properties of organic and inorganic 
nanomaterials such as graphene, carbon nanotubes, carbon fibers, and gold has resulted in 
the development of highly sensitive and stable electrochemical biosensors with significantly 
improved performance for many analytes of medical interest, including glutamate.
5. Glutamate oxidase–based biosensors
Many glutamate biosensors are based on quantifying the oxidation of hydrogen peroxide 
(H
2
O
2
) liberated in a chemical reaction between glutamate oxidase (GmOx, an oxidoreduc-
tase enzyme, EC 1.4.3.11) and L-glutamate in the presence of oxygen (O
2
), water (H
2
O), and 
a flavin adenine dinucleotide (FAD) cofactor [27–45]. GmOx enzyme catalyzes the oxidative 
deamination of glutamate resulting in the formation of 2-oxoglutarate (i.e., α-ketoglutarate, 
α-KG), ammonia (NH
3
), and H
2
O
2
 [46].
  L-glutamate +  O 
2
 +  H 
2
  O → 2-oxoglutarate +  NH 
3
 +  H 
2
 O 
2
 (1)
The oxidation of hydrogen peroxide occurs at the electrode surface or at very short distances 
away within the sample solution. The resulting current (i.e., detectable signal) which is pro-
portional to the concentration of redox active species is then quantified by the transducer.
GmOx is a highly selective enzyme [47] and therefore unlike for many catalytic enzyme-based 
biosensors, interference from unwanted enzymatic reactions with similar molecular species is 
not a major concern for these glutamate biosensors. However, there is one study which men-
tions that a GmOx enzyme had a slight sensitivity (0.6 %) for L-aspartate, an amino acid with 
a similar side-chain group to L-glutamate [46].
In addition, electrooxidation of the GmOx-generated hydrogen peroxide requires relatively 
high positive potential at which common electroactive interferents, such as ascorbic acid and 
dopamine, also undergo oxidation thereby adding to the current (i.e., the signal) [48]. Thus, 
the elimination of interference in glutamate biosensors that utilize GmOx as the biorecogni-
tion molecule is critical. Strategies for the elimination of this interference by other electroac-
tive species (which are commonly found in the sample matrix) include coating the biosensor 
with permselective nonconductive or conductive polymers such as Nafion, cellulose acetate, 
o-polyphenylenediamine (PPD), polypolyaniline, polythiophene, or polypyrrole [9, 48, 49]. 
The idea behind the addition of a permselective membrane is that the small pores within 
the membrane or film will only allow certain small molecules to pass through therefore 
minimizing interference by other larger electroactive species (see Figure 2). Also, positively 
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charged groups such as those found in sulfonated tetrafluoroethylene copolymer (Nafion) 
will prevent or minimize the diffusion of anionic sample components, such as ascorbic acid, 
across the membrane and onto the electrode surface where the redox reactions are detected. 
Furthermore, though membranes and composites incorporating permselective conducting 
polymers such as polypyrrole (PPY) have other desirable properties (such as high conduc-
tivity and being redox active), it should be noted that coating the biosensor transducer with 
these polymeric films can lead to longer response times and lower signals due to the added 
diffusion barrier for both the substrate for the enzyme and the redox active species produced 
in the enzyme-catalyzed reaction. Co-immobilization of peroxidase with a redox polymer 
[50], immobilization of ascorbate oxidase [9], and self-referencing [51] have also been utilized 
as strategies to minimize interference from other electroactive species. On the other hand, 
performing electrochemical peroxidation, a process that utilizes sacrificial electrodes and stoi-
chiometrically balanced applications of hydrogen peroxide to efficiently destroy interfering 
species in the aqueous phase, poses a risk of also oxidizing the analyte of interest.
Many glutamate biosensors based on the GmOx-catalyzed reaction also include redox media-
tors or a second enzyme that reacts with H
2
O
2
 and are often referred to as second-generation 
biosensors. By incorporating a redox mediator, it is possible to lower the potential required 
for the H
2
O
2
 oxidation, thereby further limiting interference in complex biological samples by 
other species present, such as ascorbic acid or uric acid, which may also be redox active at the 
higher detection potential. Commonly used redox mediators in enzymatic biosensors include 
ferrocyanide [12], ferrocene and ferrocene derivatives [52–54], osmium complexes [55], qui-
nine derivatives, and hexacyanoferrates, such as Prussian blue [45, 56, 57] and Ruthenium 
purple [58].
Figure 2. Elimination of interference in glutamate biosensors based on GmOx enzyme.
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Prussian blue is the oldest coordination compound and was serendipitously discovered by 
Diesbach, an artist in 1704. It possesses excellent electrochemical characteristics and exceptional 
catalytic properties, making it a popular redox mediator. It is often referred to as the “artificial 
peroxidase” and has been well characterized and incorporated into various high-performing 
enzyme-based biosensors due to its excellent electrocatalysis toward the reduction of enzyme-
generated H
2
O
2 
[45, 57, 59, 60]. Prussian blue is electrochemically reduced to form Prussian white 
(PW) which can then catalyze the reduction of H
2
O
2
 at low potentials of 0 V versus Ag/AgCl 
reference electrode [59].
6. Glutamate dehydrogenase–based biosensors
Another commonly used enzyme utilized in glutamate biosensors is L-glutamate dehydroge-
nase (GLDH) [49, 61–67]. GLDH (EC 1.4.1.2) catalyzes the deamination of amino acids, specif-
ically the oxidative deamination of L-glutamate to 2-oxoglutarate (i.e., α-ketoglutarate) in the 
presence of nicotinamide adenine dinucleotide (NAD+) which serves as an oxidized cofactor 
for the enzyme. In mammals, this reversible enzyme-catalyzed reaction strongly favors the 
formation of ammonium (NH
4
+) and 2-oxoglutarate.
  L-glutamate +  NAD + +  H 
2
  O ↔ 2-oxoglutarate +NADH +  NH 
4
   + +  H + (2)
Glutamate biosensors have also been fabricated wherein both GLDH and GmOx are co-
immobilized on the transducer surface [68]. Basu et al. co-immobilized both enzymes on 
a polycarbonate membrane by cross-linking procedures, involving glutaraldehyde, in the 
presence of a bovine serum albumin (BSA) spacer molecule in order to develop a biosen-
sor for quantification of MSG in food. The MSG biosensor utilized substrate recycling 
which resulted in the amplification of the transducer response, thereby increasing the 
sensitivity [68].
On the other hand, rather than directly detecting the glutamate levels, Meng et al. quanti-
fied glutamate by the detection of the anodic current of enzymatically generated NADH 
[67]. The electron transfer kinetics of the oxidation of NADH is sluggish and the direct oxi-
dation of NADH at bare electrodes requires a high overpotential (0.7–1.0 V), where many 
interferences can occur. Also, bare electrodes are more likely to be affected by fouling which 
is caused by the adsorption of oxidation products onto their surfaces. The authors over-
came these challenges by preparing biocompatible biosensors utilizing thionine (Th) and 
single-walled carbon nanotubes (SWCNT) nanocomposite to catalyze the electrochemical 
oxidation of NADH at an anodic potential of less than 0.19 V versus a standard hydrogen 
electrode (SHE) [67].
Azmi et al. also developed a spectrophotometric biosensor based on GLDH that was immo-
bilized in chitosan for the determination of ammonium in water samples [69]. Ammonium, 
which is known to be toxic even at low concentrations to various organisms, is widely used 
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in the farming, chemical, and automotive industries. In addition, ammonium is used as a 
parameter in the assessment of drinking and industrial water quality. The authors immobi-
lized GLDH in a chitosan film (a natural biopolymer which can found in the exoskeleton of 
crustaceans) and measured ammonium in water based on NADH oxidation in the presence 
of α-ketoglutaric acid. The biosensor had a detection limit of 0.005 mM and a linear range of 
0.005–0.5 mM NH
4
+ [69].
Chitosan GLDH film is a popular enzyme immobilization matrix for biosensors due to certain 
advantageous properties of chitosan such as being nontoxic, biocompatible, biodegradable, 
an effective antibacterial, having high mechanical strength, good adhesion, and containing 
numerous amino and hydroxyl groups. Other glutamate sensing materials include polymer/
enzyme composites [70, 71], nanoparticle iridium/carbon film [72], DNA-Cu(II)/polyamine 
membrane [73], nanoneedles [74], ferrocene functionalized SWCNT interdigitated construc-
tion film [52], Prussian blue film [45], and others.
7. Optimization of experimental conditions and measurement platforms
The topography of the prepared electrodes is usually studied using scanning electron micro-
scope (SEM). SEM imaging allows for evaluation of uniformity and dispersity of the materi-
als within the hybrid films. For example, it is possible to see if the composite materials are 
distributed uniformly over the entire surface of the electrode transducer. Agglomeration (i.e., 
sticking of particles to one another forming large groups) is sometimes observed in SEM 
images when the composites do not cover the surface uniformly. Porosity of the composite 
materials may also be assessed based on SEM images. The three-dimensional nanostructure 
morphology gives an indication whether the enzymes in the hybrid film will be accessible to 
the substrates. Modified electrodes are also much less likely to suffer from surface fouling, 
which results from adsorption of oxidation products to electrode surfaces when compared to 
bare electrodes.
As stated earlier, the incorporation of conductive nanomaterials, such as CNTs, into the 
hybrid film on a modified electrode surface is gaining popularity. CNTs often significantly 
improve electron transfer and kinetics [75]. This is due to the electrical properties of CNTs 
which vary significantly and depend on the structural differences between CNTs, resulting 
in some CNTs being highly conductive like metals, while others act more like semiconduc-
tors [76]. The current carrying capacity of certain CNTs can be up to 1000 times greater 
than that of a copper wire [77]. Furthermore, CNTs provide a tremendous increase in the 
surface area onto which enzymes or other biomolecules may be immobilized, which ulti-
mately improves quantification of the chemical reaction that is being analyzed. CNTs are 
also ideal for use in biosensors as they are nontoxic, nanometer sized, strong, and chemi-
cally stable [76].
The electrochemical performance of the modified electrodes is often evaluated using redox 
reactions of benchmark species such as Fe(CN)63−/Fe(CN)64− redox pair in cyclic voltammetry 
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(CV) studies. CV of this redox pair can be obtained using –300 mV initial potential, +800 mV 
switching potential, and –300 mV final potential with a carbon-based electrode against an Ag/
AgCl reference electrode. The effect of changing scan rates (e.g., ranging from 30 to 120 mV/s) 
on electrochemical behavior is often also studied. Moreover, other neurotransmitters such 
as dopamine, which can directly undergo oxidation to dopamine-o-quinone at the electrode 
surface, may be detected in the living brain using voltammetry.
Characterization of modified electrode nanomaterials such as CNTs may be carried out 
by UV/Vis spectroscopy or Fourier transform infra-red (FTIR) spectroscopy. For exam-
ple, Meng et al. utilized UV/Vis spectroscopy from 200 –800 nm [67] in their investiga-
tions. To confirm that thionine (Th) had adsorbed onto the SWCNT surface, the authors 
observed the occurrence of a notable absorption peak at about 600 nm as well as a small 
shoulder peak at circa 560 nm. To determine whether GLDH, the biocatalytic molecule, 
had been successfully immobilized on the Th/SWCNT nanocomposite, a peak at about 
275 nm, which is an absorption peak characteristic for proteins, was monitored using UV 
spectroscopy.
When preparing a new biocatalytic sensor, parameters such as origin and availability of the 
enzyme, its operational and storage stability as well as immobilization procedure should also 
be carefully considered [78]. In addition, the influence of experiment conditions such as pH, 
temperature, ionic strength, and stirring on the enzyme-catalyzed reaction can be minimized 
by optimizing and keeping these conditions constant throughout the biosensor use. For exam-
ple, GLDH-based biocatalytic sensors have utilized pHs ranging from 7.0 to 9.0 during the 
detection step [12, 67, 79]. Also, GmOx-based biosensors appear to utilize pHs from 7.0 to 
7.4 [40, 68]. Of note, the optimal pH of the immobilized enzyme may be slightly different 
from the free enzyme in buffered aqueous solution. Furthermore, the detection temperatures 
which the enzymes are exposed to may vary depending on the specific application of the 
L-glutamate biosensor. The concentration of coenzyme NAD+ will also need to be optimized 
for GLDH-based biosensors. Furthermore, the activity of enzymes such as GLDH (a hexa-
meric enzyme from bovine liver) is affected by various cations and anions. Specifically, lan-
thanide (La3+) and europium (Eu3+) ions can enhance the activity of bovine GLDH, at least in 
solution [80]. Also, Meng et al. observed a decrease in catalytic currents generated by GLDH 
when Zn2+ was added to the solution with the inhibitory effect increasing with increasing 
concentrations of the zinc ions [67].
Amperometry is perhaps the most common electrochemical detection method used in 
quantitative analysis of an analyte once the biosensor has been characterized and opti-
mized. It is a very popular electroanalytical detection method for quantitative analysis due 
to its simplicity and the low detection limits that can be achieved. In amperometry, the 
analyte concentration is determined by measurement of the signal—the current produced 
in a redox reaction as a function of time when a constant potential is applied to the elec-
trodes. Amperometry results in current versus time plots where the current increases step-
wise with each successive addition or formation of the redox active species. Amperometric 
signal response consisting of back-to-back steps in a “staircase” makes it relatively easy to 
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identify the starting and final current for each analyte addition or the formation of redox 
active species. The response in amperometry is usually rapid and reaches a dynamic equi-
librium which results in a steady-state current signal within seconds. The electron transfer 
of reactants during electrochemical oxidation is mainly determined by the conductivity 
of the working electrode material and the active functional groups on its surface. Three 
electrode systems with working, reference, and auxiliary electrodes are typically used in 
amperometry. In amperometry, the oxidation or reduction potential used for the detection 
step is characteristic of the analyte species, thus adding to selectivity of the method by 
eliminating interferences from other redox active species that may also be present in the 
sample. Also, the detection potential is stepped directly to the desired, optimum value, and 
current resulting from the redox reaction is detected by the transducer (the working elec-
trode in the biosensor). Current generated by the reaction (i.e., the current passing through 
the electrochemical cell over time) is proportional to the concentration of the electroactive 
species in the sample. Sometimes, the charging current or background current (i.e., the 
current needed to apply the potential to the system) present at the beginning of each mea-
surement requires some time in order to stabilize before quantitative measurements can be 
made using amperometry.
In order to be considered as an alternative to any existing and well-established instrumental 
analysis methods, such as high-performance liquid chromatography (HPLC) or spectropho-
tometry for quantification of L-glutamate in clinical or food applications, the performance 
of new biosensor devices has to be tested in serum or food samples, respectively. Ideally, 
no sample pretreatment other than dilution should be required. Also, the use of low-cost 
and disposable devices such as screen printed carbon electrodes (SPCE) is advantageous 
in the analysis of biological fluids where contamination may be a problem. Hughes et al. 
described the development and optimization of a disposable screen-printed amperometric 
biosensor for glutamate based on GLDH [79]. The authors also developed a stable, reagentless 
amperometric glutamate biosensor by incorporating the GLDH biorecognition components 
using a layer-by-layer deposition involving chitosan and MWCNTs on SPCE [81]. The new 
reagentless biosensor was applied to the measurement of glutamate in beef stock cubes and 
serum samples.
8. Figures of merit and the performance of glutamate biosensors
When new biosensors are being developed and characterized, it is common to report their 
detection limit, sensitivity, specificity, accuracy, reproducibility (i.e., precision), response 
times, reusability including recovery times, long-term stability (i.e., shelf-life), lifetime, and 
performance in real samples such as serum or soup [13, 82]. For electrochemical biosensors, 
reporting the electrode material and type as well as the transducer’s surface area and detec-
tion potential versus a reference electrode are also important experimental details. Table 1 
summarizes many of these analytical figures of merit for selected glutamate biosensors allow-
ing comparisons to be made between various enzyme-based biosensors.
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Electrode Configuration Application Enzyme Optimal pH Applied potential Response 
time
LOD Linear range Ref.
Screen-printed 
graphite
CHIT/MB/SPCE In vitro GLDH 7 0.1 V vs. Ag/AgCl 2 s 1.5 μM 12.5–150 μM Hughes [79]
Platinum 
microelectrode 
array
Silicon wafer/
polypyrrole/
Nafion
In vivo GmOx 7.4 0.7 V vs. Ag/AgCl <1 s <1 μM 10–100 μM Wassum [40]
Oxygen electrode Glutaraldehyde/
bovine serum 
albumin
In vitro (food) GmOx and 
GLDH
7 120 d 0.02 mg/L 0.02–1.2 mg/L Basu [68]
Glassy carbon 
electrode
SWCNT/thionine NADH GLDH 8.3 0.19 V vs. Ag/
AgCl
5 s 0.1 μM 0.5–400 μM Meng [67]
Au planar 
nanocomposite
CHIT/MWCNT/
ferricyanide
In vitro (food) GLDH and 
diaphorase
9 <60 s 5.4 μM 10–3495 μM Monošík [12]
SWCNT bundles Ferrocene/SWCNT In vitro 0.2 V vs. Ag/AgCl <300 s 1 μM 1–7 μM Huang [52]
Pt. microelectrode CHIT/ceria & 
titania NPs
In vitro 
(hypoxic brain 
tissue)
GmOx 0.6 V vs. Ag/AgCl 2–5 s 0.594/0.493 μM Özel [44]
Graphite PB/graphite Proof of 
concept
GmOx 6.5 −0.05 V vs. Ag/
AgCl
3 s 0.01 μM 0.01–0.1 mM Liu [45]
Au electrode cMWCNT/AuNP/
chitosan
In vitro (sera) GmOx 7.5 0.135 V vs. Ag/
AgCl
2 s 1.6 μM 5–500 μM Batra [83]
Vertically 
aligned CNT 
nanoelectrode 
array
VACNT-NEA Proof of 
concept
GLDH 0 V vs. Ag/AgCl 57 nM 0.1–300 μM Gholizadeh 
[75]
Pt electrode Chitosan-glutaric 
dialdehyde gels
Proof of 
concept
GmOx 0.6 V vs. Ag/AgCl 2 s 0.10 μM 0.10–500 μM Zhang [37]
Pt electrode Chitosan In vitro (food) GmOx 0.4 V vs. Ag/AgCl 2 s 0.10 μM 1–10 μM Zhang [38]
Patterned Pt thin 
film electrodes
Glutaraldehyde/
SiO
2
/PCB
Cell culture 
fermentation
GmOx 0.6 V vs. Ag/AgCl 0.0002 μM 0.00022500 
μM
Bäcker [41]
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Electrode Configuration Application Enzyme Optimal pH Applied potential Response 
time
LOD Linear range Ref.
SAM on smart 
biodevice
ECD/thioglycolic 
acid
Proof of 
concept
GmOx NA 0.089 μM 0.1–10,000 
μM
Rahman [42]
Pt electrode Glutaraldehyde In vitro (brain 
tissue) uptake
GmOx 7.4 0.6 V vs. Ag/AgCl 15–20 s 0.5 μM 2–800 μM Soldatkin 
[84]
Screen-printed 
graphite
MWCNT-
CHIT-MB/
CHIT-NAD+-MB/
MWCNT-
CHIT-MB/
MB-SPCE
In vitro proof 
of concept
GLDH 7 0.1 V vs. Ag/AgCl <60 s 3 μM 7.5–105 μM Hughes [81]
Table 1. A summary of previously published electrochemical glutamate biosensors, their electrode material, surface modification configuration, analytical figures of merit, 
and authors.
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9. Conclusion
Enzyme-based electrochemical glutamate biosensors have tremendous potential for manufac-
turing of cost-efficient, easy-to-use, fast, and portable alternatives for a wide range of appli-
cations from medical/clinical testing or neurological studies for diagnostics involving this 
important neurotransmitter in vivo or in vitro to environmental monitoring, process monitor-
ing, and food-sensing applications [13, 82]. Electrochemical detection schemes are also typi-
cally very simple, sensitive, independent of sample volume, and well suited for monitoring 
glutamate from nM to μM in real samples such as biological fluids or processed foods. The 
incorporation of the oxidase or dehydrogenase enzyme as the biorecognition component on 
the electrochemical transducer provides additional selectivity and in some detection schemes 
even significant signal enhancement. Many glutamate biosensors are label free while oth-
ers incorporate various redox active mediator molecules into a composite material on the 
biosensor surface. An increasing number of enzyme-based glutamate biosensors also utilize 
the advantageous properties of nanomaterials such as biocompatible CNTs or metal nanopar-
ticles. It is likely to take years or a decade before many of these biosensors described in this 
chapter go from proof-of-concept stage to mass production of inexpensive, small, and reli-
able devices capable of competing with existing instrument-intensive laboratory methods for 
glutamate quantification such as spectroscopy or chromatography. However, with continu-
ous developments in molecular biology, nanofabrication methods, immobilization methods 
of biomolecules, and multiplexing capabilities, the production of sensitive, selective, fast, and 
easy-to-use biosensors for quantification of glutamate and other neurotransmitters will be 
feasible in the not too distant future.
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